Delivery Order SPE2DR25D1053-SPE2DR26FV343
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,766.64 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 20 mg tablets (100 count) on December 23, 2025, with an ultimate completion date of December 24, 2025. This is a firm fixed price, non-set-aside delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $1,952.64 to AmerisourceBergen Drug Corp for Dextroamphetamine 20mg tablets (100 count) on November 26, 2025, with completion targeted for December 24, 2025. This competitive award, made without set-aside provisions, represents a firm fixed-price delivery order for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets (100 count) on September 4, 2025, with a ceiling value of $1,034.62 and completion date of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.34 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 10 mg on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100, with a ceiling value of $2,114.40. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100, with a ceiling value of $2,364.02 and an ultimate completion date of January 2, 2026. This is a firm fixed price delivery order issued under a competitive, non-set-aside procurement. The contract will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,966.33 for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on August 7, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,239.90 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100 count) on December 9, 2025, with a completion date of December 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug...
- AmerisourceBergen Drug Corp was awarded a delivery order on January 5, 2026, by the Defense Logistics Agency to supply 100 capsules of Dextroamphetamine-Amphetamine 10 mg with a ceiling value of $1,231.74. The contract is firm fixed price, non-competitive set-aside, and scheduled for completion by January 6, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,803.01 to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on November 18, 2025, with ultimate completion scheduled for November 19, 2025. The contract utilizes firm fixed-price pricing and includes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV343Delivery Order
On January 8, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,166.16 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine 10 mg tablets (100 count). This competitively awarded, firm fixed-price contract carries no set-aside designation and requires completion by January 9, 2026. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive vehicle enables the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. Through this IDC structure, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems with flexible and responsive pharmaceutical support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/7/26 |